Latest
Vitamin D May Reduce Immune Checkpoint Inhibitor–Related Colitis
Active Anticancer Treatment Associated With Poor COVID-19 Prognosis
Genetic Tests May Differ in Their Interpretation of Certain Variants
COVID-19 Drug Remdesivir Could Cost Up to $3120 Per Patient
Study Finds Vancomycin Increased Risk for Cytomegalovirus Reactivation After Hematopoietic Cell Transplant
Good Diet May Cut Toxicity Risk in Treatment of Pediatric ALL
Methotrexate-Induced Acute Kidney Injuries in Patients with Hematologic Malignancies
Graft, Survival Outcomes After Liver Transplant in Patients With Sickle Cell Disease
Study Finds Higher Incidence of Atrial Fibrillation With Ibrutinib Therapy
Benefit From CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell ALL
Immunoglobulin Assessment For Stratifying Prognosis, Target Therapy in AML
Loss of Limb Mobility in a Patient With T-ALL Treated With Nelarabine
Featured Content
Treating Strategies for Patients With Relapsed/Refractory Acute Myeloid Leukemia
Although numerous clinical studies have aimed to treat AML, most results have been disappointing, according to authors of a publication in Blood.
Treatment, Remaining Needs Pertaining to Acute Myeloid Leukemia
The current state of AML treatment and remaining needs are discussed in an interview with Courtney D. DiNardo, MD, MSCE and Ghayas C. Issa, MD.
Direct-to-Drug Screening Tool Allows for Precision Medicine in Multiple Myeloma
An assay from Mayo Clinic researchers screens multiple myeloma drugs to see how cells with different biomarkers and pretreatment histories react.
New ASCO Clinical Guidelines on Management of Cancer Cachexia
The American Society of Clinical Oncology published new clinical guidelines on the management of cachexia in adults with advanced cancer.
von Willebrand Disease: Recent Developments in Diagnosis, Treatments
New developments in lab assays have allowed for more specialized assessments of VWD activity, leading to better diagnoses and various treatment options.
-
Loading...
-
Loading...
